In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated ...

The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns ...

The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...

If you were prescribed a GLP-1, it's important that you understand how your insurance coverage works in order to stay on top ...

Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...

New study results found weight loss and diabetes drugs Zepbound and Mounjaro may significantly cut the risk of diabetes in people with prediabetes and obesity, adding to the growing list of ...

All of those patients were either taking oral diabetes medications SGLT-2 or DPP-4 inhibitors ... “They are on the gold standard treatment list for congestive heart failure, too,” she says.

The list price of both Mounjaro and Zepbound ... citing heart disease and diabetes, for which the drugs are already approved, ...

Pharmacist Mark Mikhael has lost 50 pounds over the past 12 months. He no longer has diabetes and finds himself “at my ideal ...

ScienceDaily: Some Diabetes Drugs Tied To Lower Risk Of Dementia, Parkinson's Disease A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, ...

The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.

Substituting 10% of UPFs with 10% of PF reduced diabetes risk by 18%, the study suggests. The experts say this may be down to the fact that 30-50% of PF intake in this study came from beer and wine, ...